Non-Nukes or NNRTIs: Non-Nucleoside Reverse Transcriptase Inhibitors

To see a list of fact sheets in each category, click on the category name.

NOTE: You can see a full list of fact sheet topics on Fact Sheet 1000.

 

430. Non-Nucleoside Reverse Transcriptase Inhibitors in Development
A description of non-nucleoside reverse transcriptase inhibitors in development against HIV.
[Revised November 23, 2009]

431. Nevirapine (Viramune)
A description of the antiretroviral drug nevirapine (Viramune®), including dosing, side effects, and a general discussion of who should take this drug.
[Revised July 29, 2010]

432. Efavirenz (Sustiva, Stocrin)
What is Efavirenz?
[Revised April 16, 2010]

433. Delavirdine (Rescriptor)
A description of the antiretroviral drug delavirdine (Rescriptor®), including dosing, side effects, and a general discussion of who should take this drug
[Revised November 24, 2009]

434. Etravirine (Intelence)
A description of the antiretroviral drug Etravirine (Intelence), including dosing, side effects, and a general discussion of who should take this drug.
[Reviewed August 6, 2010]

439. Atripla (efavirenz + emtricitabine + tenofovir)
A description of the three-in-one combination antiretroviral drug (ARV) Atripla®, including dosing, side effects, and a general discussion of who should take this drug
[Reviewed August 6, 2010]